Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hirsch

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Journal of Cardiology|September 28, 2005
Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goalsMark Hirsch, John O'donnell, Anders Olsson
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|February 11, 2005
Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trialMark Hirsch, John C O'Donnell, Peter Jones
American Journal of Physical Medicine & Rehabilitation|January 19, 2017
Recurrent Median Nerve Injury in a Weight LifterMichael A Worobel, Bobby Alexander, Mark Hirsch, et al.
The Journal of Sexual Medicine|January 21, 2006
Standards for clinical trials in male sexual dysfunction: erectile dysfunction and rapid ejaculationMark Hirsch, Craig Donatucci, Sidney Glina, et al.
Urology|October 19, 2005
Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?Scott Ramsey, David Veenstra, Lauren Clarke, et al.
Androgens: Clinical Research and Therapeutics|May 27, 2021
Testosterone Therapy for the Treatment of Age-Related Hypogonadism: Risks with Uncertain BenefitsChristine P Nguyen, Mark Hirsch, Suresh Kaul, et al.
The Journal of Urology|July 12, 2005
The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancerDavid F Penson, Scott Ramsey, David Veenstra, et al.
Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry|March 5, 2011
Receipt of dental care and barriers encountered by persons with disabilitiesTanya Rouleau, Amanda Harrington, Michael Brennan, et al.
Health Policy (Amsterdam, Netherlands)|September 11, 2017
Time for a change in how new antibiotics are reimbursed: Development of an insurance framework for funding new antibiotics based on a policy of risk mitigationAdrian Towse, Christopher K Hoyle, Jonathan Goodall, et al.
Disability and Rehabilitation. Assistive Technology|April 16, 2026
Appropriate use recommendations for digital technology in cognitive telerehabilitation for people living with Parkinson's diseaseSanghee Moon, Iracema Leroi, Sandra Kletzel, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Cardiology|September 28, 2005
Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goalsMark Hirsch, John O'donnell, Anders Olsson
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|February 11, 2005
Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trialMark Hirsch, John C O'Donnell, Peter Jones
American Journal of Physical Medicine & Rehabilitation|January 19, 2017
Recurrent Median Nerve Injury in a Weight LifterMichael A Worobel, Bobby Alexander, Mark Hirsch, et al.
The Journal of Sexual Medicine|January 21, 2006
Standards for clinical trials in male sexual dysfunction: erectile dysfunction and rapid ejaculationMark Hirsch, Craig Donatucci, Sidney Glina, et al.
Urology|October 19, 2005
Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?Scott Ramsey, David Veenstra, Lauren Clarke, et al.
Androgens: Clinical Research and Therapeutics|May 27, 2021
Testosterone Therapy for the Treatment of Age-Related Hypogonadism: Risks with Uncertain BenefitsChristine P Nguyen, Mark Hirsch, Suresh Kaul, et al.
The Journal of Urology|July 12, 2005
The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancerDavid F Penson, Scott Ramsey, David Veenstra, et al.
Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry|March 5, 2011
Receipt of dental care and barriers encountered by persons with disabilitiesTanya Rouleau, Amanda Harrington, Michael Brennan, et al.
Health Policy (Amsterdam, Netherlands)|September 11, 2017
Time for a change in how new antibiotics are reimbursed: Development of an insurance framework for funding new antibiotics based on a policy of risk mitigationAdrian Towse, Christopher K Hoyle, Jonathan Goodall, et al.
Disability and Rehabilitation. Assistive Technology|April 16, 2026
Appropriate use recommendations for digital technology in cognitive telerehabilitation for people living with Parkinson's diseaseSanghee Moon, Iracema Leroi, Sandra Kletzel, et al.
Pageof 2